The next trillion-dollar industry won’t be social media, crypto or even AI. It will be longevity — the business of extending not just how we live, but how well we live. https://t.co/dwikoxup9X
#lifespan#healthspan#longevity
Hello #Vancouver business and #investment community. We will be hosting a Meet and Greet for two very exciting Vancouver-based companies @DermBiome and @PanBiome on February 19th at Rodney’s Oyster Bar in Vancouver. Please join! #bctech#biotech
The gut microbiome holds a central role in human aging. By modulating the gut microbiome it may be possible to slow down the aging process, reduce the risk of age-related diseases, and promote healthier aging. #longevity#lifespan#healthspan
https://t.co/VzvAe1YsHi
.@PanBiome's lead compound exhibited protective effects in an #InflammatoryColitis model!
“While we are still working out the mechanism, our compound most likely optimizes mitochondrial functionality," says CSO Dr. Poul Sorensen.
🔗 https://t.co/O5MLGKAcfc
We are a biotech company focused on age-related diseases and extending #healthspan. We are raising a pre-#seedround to help advance our lead compound in several important diseases. Let us tell you more about this exciting opportunity #longevity#angelinvestor
We are very happy to announce positive results from a preclinical trial of colitis. We have a compound that shows great promise to delay the onset of age-related diseases and extend how long we live disease-free. #healthspan#longevity#aging https://t.co/0vrpsgW8CA
Pan-Biome reports positive results in gut #microbiome modulator trial
Lead compound exhibits protective effects in inflammatory colitis, modulates gut microbiome and extends lifespan in C elegans.
@PanBiome#biotech#guthealth#colitis#longevity
https://t.co/bT6kxlJrHg
C. difficile isn't only an issue within hospitals and can affect outpatients. Preserving gut microbiome richness is vital in managing C. difficile infection, but current antibiotics work in the opposite way https://t.co/7n25c460dp #GMFH10Years
Longevity Biomedical and #SPACDenali to create Nasdaq-listed longevity biopharm company
New company will focus on advancing new tech to promote human health and longevity.
#biopharma#healthspan#longevity#NASDAQ
https://t.co/4LGErJdfHB
One of the biggest global challenges facing healthcare systems is bacteria and viruses becoming resistant to drugs. 👇🏻
#biotech#lifesciences#news
https://t.co/StcduQvipU
Derm-Biome Pharmaceuticals, Inc. adds skin disease and microbiome specialists Drs. Youwen Zhou and Andy Sham to Its Newly Created Scientific Advisory Board https://t.co/hsSgEPy0e5
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome. https://t.co/otkOVL75dI
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome #microbiome#guthealth#bctech https://t.co/otkOVL75dI